Literature DB >> 6623354

Interval breast cancer: a more aggressive subset of breast neoplasias.

R DeGroote, B F Rush, J Milazzo, M J Warden, J M Rocko.   

Abstract

It has been suggested that interval breast cancer (breast cancer found within 12 months of a negative screening examination) exhibits a more virulent behavior than those found by the screening clinic. To test this hypothesis, 120 new cases of breast cancer were retrospectively reviewed from our Breast Screening Center. These patients were divided into three groups--interval cancer cases, lesions found at initial screening, and lesions found at subsequent screening. Statistically significant differences seen in our interval cancer cases included a higher percentage of positive axillary nodes, higher overall mortality rate, and lower 6-year survival rate as calculated by left table analysis. The remaining data, although not statistically significant, demonstrate a parallel trend toward a more malignant behavior. It is concluded that interval breast cancers are more aggressive forms of breast neoplasias.

Entities:  

Mesh:

Year:  1983        PMID: 6623354

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  13 in total

1.  Screening for breast cancer: current status, problems, prospects.

Authors:  J E Devitt
Journal:  Can Fam Physician       Date:  1985-01       Impact factor: 3.275

2.  High expression of the trefoil protein TFF1 in interval breast cancers.

Authors:  M Crosier; D Scott; R G Wilson; C D Griffiths; F E May; B R Westley
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

3.  Discovery of breast cancers within 1 year of a normal screening mammogram: how are they found?

Authors:  Patricia A Carney; Elizabeth Steiner; Martha E Goodrich; Allen J Dietrich; Claudia J Kasales; Julia E Weiss; Todd MacKenzie
Journal:  Ann Fam Med       Date:  2006 Nov-Dec       Impact factor: 5.166

4.  Assessment of malignancy potential in so-called interval mammary carcinomas.

Authors:  A von Rosen; K Erhardt; L Hellström; A Somell; G Auer
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

5.  Locally advanced breast cancers are more likely to present as Interval Cancers: results from the I-SPY 1 TRIAL (CALGB 150007/150012, ACRIN 6657, InterSPORE Trial).

Authors:  Cheryl Lin; Meredith Becker Buxton; Dan Moore; Helen Krontiras; Lisa Carey; Angela DeMichele; Leslie Montgomery; Debasish Tripathy; Constance Lehman; Minetta Liu; Olufunmilayo Olapade; Christina Yau; Donald Berry; Laura J Esserman
Journal:  Breast Cancer Res Treat       Date:  2011-07-28       Impact factor: 4.872

6.  Analysis of interval breast carcinomas in a randomized screening trial in Stockholm.

Authors:  J Frisell; G Eklund; L Hellström; A Somell
Journal:  Breast Cancer Res Treat       Date:  1987       Impact factor: 4.872

7.  Interval cancer and survival in a randomized breast cancer screening trial in Stockholm.

Authors:  J Frisell; A von Rosen; M Wiege; B Nilsson; S Goldman
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

8.  Does delay in diagnosis of breast cancer affect survival?

Authors:  L M Neave; B H Mason; R G Kay
Journal:  Breast Cancer Res Treat       Date:  1990-02       Impact factor: 4.872

9.  Breast cancer detected by mass screening using physical examination alone.

Authors:  T Morimoto; K Komaki; K Oshimo; T Yamakawa; N Mitsuyama; T Tanaka; Y Monden
Journal:  Jpn J Surg       Date:  1987-09

10.  The epidemiological profile of women with an interval cancer in the DOM screening programme.

Authors:  C T Brekelmans; P H Peeters; J A Faber; J J Deurenberg; H J Collette
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.